| scholarly article | Q13442814 |
| P2093 | author name string | Harald Arnesen | |
| Ingebjørg Seljeflot | |||
| Ida Unhammer Njerve | |||
| Rune Byrkjeland | |||
| Sissel Åkra | |||
| Svein Solheim | |||
| P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Use and abuse of HOMA modeling | Q28263292 | ||
| A new class of membrane-bound chemokine with a CX3C motif | Q28303204 | ||
| Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients. | Q33794941 | ||
| Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review | Q33870787 | ||
| Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors | Q34432988 | ||
| The effect of physical activity or exercise on key biomarkers in atherosclerosis--a systematic review. | Q35170005 | ||
| A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis. | Q35630828 | ||
| Fractalkine is a novel human adipochemokine associated with type 2 diabetes | Q35796996 | ||
| Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males | Q35902368 | ||
| Functional changes in adipose tissue in a randomised controlled trial of physical activity | Q36329196 | ||
| A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial | Q36335205 | ||
| Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies | Q36833317 | ||
| Inflammation in atherosclerosis: transition from theory to practice | Q37672113 | ||
| Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease | Q37699743 | ||
| Differential expression of the fractalkine chemokine receptor (CX3CR1) in human monocytes during differentiation | Q43083885 | ||
| Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study | Q43189551 | ||
| Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy | Q46191844 | ||
| Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue | Q46583275 | ||
| Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. | Q46849818 | ||
| Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. | Q47402154 | ||
| Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial. | Q53460940 | ||
| CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. | Q53476231 | ||
| A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. | Q53847918 | ||
| Identification of human exercise-induced myokines using secretome analysis | Q55162867 | ||
| Chemokines control fat accumulation and leptin secretion by cultured human adipocytes | Q57076426 | ||
| Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease | Q84782010 | ||
| Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus | Q84809052 | ||
| Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD | Q85674366 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | coronary artery disease | Q844935 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 55-62 | |
| P577 | publication date | 2016-03-14 | |
| P1433 | published in | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | Q5270108 |
| P1476 | title | Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial | |
| P478 | volume | 9 |
Search more.